Sponsor or institution

Clinical trials and research at The First Affiliated Hospital of Soochow University

• 90Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (90)

• CD20 antibody to prevent early EBV activation after a first allogeneic stem cell transplant

  Researchers are testing whether a CD20 monoclonal antibody can prevent EBV activation in people aged 14 to 70 after their first allogeneic stem cell transplant.

  Recruiting Phase 2/3 The First Affiliated Hospital of Soochow University · Hefei, Anhui and 9 other locations · NCT07929974

• BEBT-908 treatment for MEF2D-rearranged B-ALL that has come back or isn’t controlled

  This study tests BEBT-908 given IV to see if it can help people aged 14–75 with MEF2D-rearranged B-cell precursor ALL who have relapsed, are refractory, or still have measurable disease after treatment.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou · NCT07854652

• CMV-specific T cells after CMV reactivation in adults after HSCT

  This study tests CMV-specific immune recovery in adults who have their first CMV reactivation after an allogeneic HSCT to see how CMV-specific T cells change over time.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07688759

• Venetoclax and Azacitidine Consolidation After Remission in Intermediate-Risk AML

  We’re testing if a venetoclax-plus-azacitidine consolidation approach works as well as standard high-dose chemotherapy for adults with intermediate-risk AML who have already achieved remission and are headed to stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07672262

• Venetoclax TDM in newly diagnosed AML: exposure and prognosis

  This study checks if measuring venetoclax levels and adjusting treatment helps people with newly diagnosed AML who are getting VEN-AZA.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou · NCT07670130

• First-line RN1201 CAR-T for newly diagnosed multiple myeloma

  This early, small study tests a once-dosed, donor-derived CAR-T therapy (RN1201) in adults with newly diagnosed multiple myeloma to see if it is safe and if patients respond.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07652138

• Trastuzumab Rezetecan Neoadjuvant Therapy for HER2-Positive Breast Cancer

  This trial tests whether adding trastuzumab rezetecan after an initial THP treatment helps patients with HER2-positive breast cancer decide if they should switch therapies based on response.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07647263

• Romiplostim for Oral TPO-RA Resistant ITP

  This study tests whether adding romiplostim can help adults with immune thrombocytopenia who did not respond to oral TPO-RAs.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07612319

• VR-MBCT for chronic nonspecific low back pain

  A multi-center trial will test whether adding virtual reality-based mindfulness therapy to usual care helps adults with chronic nonspecific low back pain feel better and move more in 8 weeks.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07589790

• VABu Conditioning for elderly AML patients undergoing stem cell transplant

  This trial tests a VABu conditioning regimen to see if it helps older AML patients before allogeneic stem cell transplantation.

  Recruiting Phase 2/3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07583888

• Repeated transcranial magnetic stimulation to treat diarrhea-predominant irritable bowel syndrome

  This study will test whether repeated transcranial magnetic stimulation (rTMS) can reduce diarrhea, abdominal pain, and improve quality of life in adults with IBS-D.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07581756

• Full-course immunotherapy plus chemotherapy for newly diagnosed Ph-negative B-cell ALL

  This phase 2 test gives blinatumomab throughout treatment with reduced-dose chemotherapy, and uses CAR-T cells and transplant as needed, to try to improve two-year relapse-free survival in adults with newly diagnosed Ph-negative B-cell ALL.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07564453

• Peripheral blood KIT-D816V testing in adults with systemic mastocytosis

  This will test whether a sensitive blood test (ddPCR) can find the KIT-D816V mutation in adults with systemic mastocytosis so they might avoid a bone marrow biopsy.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07562542

• Menin inhibitor maintenance after allogeneic stem cell transplant

  This project will try menin inhibitor maintenance to see if it helps people with acute leukemia after allogeneic stem cell transplant who have KMT2A or related gene changes.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07559695

• Using new non-contrast MRI sequences to improve diagnosis and grading of prostate cancer

  This project tries new non-contrast MRI scans to see if they improve diagnosis and grading for men with suspected prostate cancer and elevated PSA.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07552285

• Explainable multimodal AI for diagnosing early gastric cancer from endoscopic images

  This project will try an explainable AI that combines white-light and image-enhanced endoscopy pictures plus clinical data to help detect early gastric cancer in adults with suspicious gastric lesions who underwent endoscopic submucosal dissection.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou · NCT07551466

• Clad-LABU conditioning before allogeneic stem cell transplant for relapsed or refractory AML/MDS in older adults

  This will try a Clad-LABU chemotherapy conditioning plan before allogeneic stem cell transplant in people aged 50 and older with relapsed or refractory AML or MDS.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07500753

• Haplo‑cord versus haplo hematopoietic stem cell transplant for aplastic anemia

  This trial will test whether adding unrelated cord blood to a haploidentical stem cell transplant (haplo‑cord) helps people aged 14 and older with aplastic anemia more than a haploidentical transplant alone.

  Recruiting at 4 sites The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 3 other locations · NCT07499284

• Genetic subtype–matched first-line treatment for newly diagnosed DLBCL with TP53 mutation.

  This treatment plan will try Pola‑R‑CHP for people newly diagnosed with DLBCL and a TP53 mutation, adding orelabrutinib only for those whose tumors have the MCD/BN2 genetic subtype.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07499271

• MRD‑guided maintenance after transplant: gilteritinib versus sorafenib

  This trial tests whether taking gilteritinib or sorafenib after an allogeneic stem cell transplant helps people aged 14–70 with FLT3‑ITD–positive AML who were MRD‑positive before transplant.

  Recruiting at 2 sites Phase 3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT07463651

• Venetoclax with hypomethylating drugs and low-dose cytarabine for adults with CEBPA‑mutated AML who can't tolerate intensive chemotherapy

  This trial will try combining venetoclax with azacitidine or decitabine plus low‑dose cytarabine to treat adults newly diagnosed with CEBPA‑mutated AML who are unfit for intensive chemotherapy.

  Recruiting Phase 1/2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07451912

• Venetoclax plus azacitidine consolidation vs standard chemotherapy before stem cell transplant in high-risk AML

  This study tests whether a venetoclax-containing consolidation helps newly diagnosed high-risk AML patients who have CR/CRi after VA induction to improve outcomes before allo-HSCT.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07425782

• Romiplostim versus daily rhTPO for speeding platelet recovery after donor stem-cell transplant

  This trial will test whether a once-weekly romiplostim injection helps platelets recover faster and safely than daily rhTPO in adults 18–65 with MDS or severe aplastic anemia after a donor stem-cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07400341

• Amimestrocel infusion to prevent severe mouth sores after allogeneic stem cell transplant

  This study will try a single IV infusion of Amimestrocel in adults receiving myeloablative allogeneic stem cell transplants with TBI or melphalan to see if it prevents severe mouth sores.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhu, Jiangsu · NCT07400328

• Orelabrutinib after short-course R-CHOP for people with newly diagnosed marginal zone lymphoma

  This treatment plan will try whether taking orelabrutinib after three cycles of R-CHOP helps people with newly diagnosed marginal zone lymphoma stay in remission.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07372365

• Zeprumetostat plus azacitidine and liposomal mitoxantrone for relapsed/refractory peripheral T‑cell lymphoma

  This study will test whether combining zeprumetostat, azacitidine, and liposomal mitoxantrone can shrink tumors in adults with relapsed or refractory peripheral T‑cell lymphoma.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07372352

• CXCR4‑enabled CCR9 CAR‑T therapy for relapsed or refractory T‑cell acute lymphoblastic leukemia/lymphoma

  This trial will try a new CAR‑T cell treatment (CXCR4 CCR9 CAR‑T) in people aged 15–75 with relapsed or refractory T‑ALL/LBL to see if it is safe and can help control the cancer.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07350863

• Zanubrutinib plus rituximab for secondary HLH linked to B‑cell lymphoma

  This test tries zanubrutinib together with rituximab (plus short steroids and ruxolitinib, with emapalumab if needed) to treat people who have secondary HLH caused by B‑cell lymphoma.

  Recruiting Phase 4 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07270835

• BY002 for relapsed or refractory acute leukemia with KMT2A rearrangements or NPM1 mutations

  This trial tests an oral menin inhibitor, BY002, in adults with relapsed or refractory AML, ALL, or MPAL who have KMT2A rearrangements or NPM1 mutations to see if it is safe and shows early signs of benefit.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07270770

• Pirtobrutinib plus lisaftoclax and rituximab for relapsed or refractory DLBCL

  This trial tests whether combining pirtobrutinib, lisaftoclax, and rituximab helps people with relapsed or refractory diffuse large B‑cell lymphoma who have had at least one prior systemic therapy.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07255963

• Romiplostim N01 plus rituximab for people with primary immune thrombocytopenia unresponsive to oral TPO‑RAs

  This study will test whether weekly romiplostim N01 injections combined with a four‑week course of rituximab can raise platelet counts in people aged 14 and older whose ITP did not respond to oral TPO‑RAs.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07206823

• Gecacitinib with Corticosteroid as First‑Line Therapy for Grade II–IV Acute GVHD

  This study tests whether adding gecacitinib to standard corticosteroid therapy helps adults with newly diagnosed grade II–IV acute GVHD.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07185633

• Venetoclax with azacitidine, chidamide, vindesine, and dexamethasone for newly diagnosed ETP-ALL–like leukemia

  This test tries a five-drug combination including venetoclax and azacitidine in adults 14–65 with newly diagnosed ETP-ALL–like leukemia to see if it improves remission rates and side effects.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07159620

• BN104 maintenance after allogeneic stem cell transplant for acute leukemia

  This trial tests whether taking the oral menin inhibitor BN104 can reduce relapse in people with acute leukemia who have specific genetic changes and are 1–6 months after an allogeneic stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07101497

• ThisCART19A plus Olverembatinib for newly diagnosed Ph+ ALL

  A one-arm study tests whether ThisCART19A plus Olverembatinib can safely and effectively treat adults with newly diagnosed Philadelphia chromosome–positive ALL.

  Recruiting at 2 sites Early Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT07074496

• Teniposide plus PD-1 antibody and selinexor for relapsed or refractory primary CNS lymphoma

  This study will test whether combining teniposide, a PD‑1 antibody, and selinexor can shrink tumors and control disease in adults 18–75 with relapsed or refractory primary central nervous system lymphoma after high‑dose methotrexate.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07074470

• Chidamide plus brentuximab vedotin for CD30-positive peripheral T‑cell lymphoma in patients unfit for chemotherapy

  This treatment will test whether combining chidamide with brentuximab vedotin helps people with CD30-positive peripheral T‑cell lymphoma who cannot tolerate standard chemotherapy.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07074457

• RN1201 cells infusion for immune-mediated platelet refractoriness and immune thrombocytopenia

  This is a early-phase, single-arm trial testing RN1201 CAR-T cells in patients with antibody-mediated PTR or ITP to see if it is safe and may help restore platelet counts.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07072247

• Bendamustine plus chidamide and lenalidomide for relapsed or refractory peripheral T‑cell lymphoma

  This study will test whether combining bendamustine, chidamide, and lenalidomide helps adults with relapsed or refractory peripheral T‑cell lymphoma.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07072221

• Combining pomalidomide, rituximab, orelabrutinib and polatuzumab vedotin for elderly diffuse large B‑cell lymphoma

  This tests whether adding polatuzumab vedotin to a pomalidomide, rituximab and orelabrutinib regimen helps patients aged 70 and older with newly diagnosed diffuse large B‑cell lymphoma.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07072208

• Radiation‑optimized autologous stem cell transplant followed by sequential CAR‑T for relapsed/refractory aggressive B‑cell NHL

  This trial will try combining targeted radiotherapy, a reduced‑intensity SEAM/TB conditioning with autologous stem cell transplant, and sequential CAR‑T cell therapy in adults with relapsed or refractory aggressive B‑cell NHL to see if it improves disease control and survival.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07059741

• Multi-omics testing to distinguish benign from malignant lung nodules

  This project will test whether combining blood single-cell data, flow cytometry, and CT image features can tell if a pulmonary nodule is benign or cancerous in people scheduled for nodule surgery.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07047573

• Avapritinib with standard chemotherapy for newly diagnosed KIT‑mutant CBF‑AML

  This will test whether adding avapritinib to standard induction and consolidation therapies helps adults newly diagnosed with KIT‑mutated core‑binding factor AML achieve deeper remissions and live longer.

  Recruiting Phase 1/2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07028073

• Multiple-dose IBI3002 injections to check safety in adults with moderate-to-severe atopic dermatitis

  This trial will test multiple subcutaneous doses of IBI3002 in adults (18–65) with moderate-to-severe atopic dermatitis who haven't responded to or cannot use topical treatments.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07015762

• Multiple-dose IBI3002 injections for adults with eosinophilic asthma

  This trial will test whether multiple subcutaneous injections of IBI3002 are safe and well tolerated in adults with asthma who have high FeNO and elevated blood eosinophils.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07015749

• Venetoclax plus azacitidine for newly diagnosed ETP-like and myeloid-mutated T-cell ALL

  This trial will try venetoclax combined with azacitidine as first-line treatment for people aged 14 and older with newly diagnosed ETP-like T-ALL, T-ALL with myeloid mutations, or T/myeloid mixed-phenotype leukemia.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07012447

• New treatment for newly diagnosed IDH1-mutated acute myeloid leukemia

  This trial will try a three-drug combination—ivosidenib, venetoclax, and azacitidine—for adults in China with newly diagnosed IDH1-mutated acute myeloid leukemia.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07007949

• Full-course immunotherapy for B‑cell acute lymphoblastic leukemia patients who are unfit for or decline chemotherapy

  This study will try a full course of sequential immunotherapy with blinatumomab followed by inotuzumab ozogamicin for people with B‑cell ALL who are older, unfit for, have relapsed/refractory disease, or who decline intensive chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06985485

• Using Transcranial Magnetic Stimulation and Probiotics to Treat IBS-D

  This study is testing if a combination of brain stimulation and probiotics can help people with diarrhea-predominant IBS feel better.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06960369

• Using TBI and BUMEL for Stem Cell Transplant in AML Patients

  This study is testing a new treatment plan using total body radiation and BUMEL to see if it helps young and middle-aged adults with tough cases of acute myeloid leukemia who need a stem cell transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06879847

• Efficacy and safety of TmBU conditioning for high-risk leukemia patients

  This study is testing a new treatment approach for high-risk leukemia patients to see if it helps them stay cancer-free after a stem cell transplant better than the current method.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06816134

• Preventing CMV Infections in High-Risk Adults After Stem Cell Transplant

  This study is testing if giving a medication called letermovir for longer than usual can help prevent serious CMV infections in high-risk adults after they receive a stem cell transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06812598

• Evaluating cancer immunotherapy effectiveness in lung and esophageal cancer patients

  This study is testing how well immunotherapy works for people with lung and esophageal cancer by looking at changes in their immune cells before and after treatment.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06790797

• Low-frequency rTMS to reduce belly pain in diarrhea-predominant IBS

  This trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) to a brain region can reduce visceral (belly) pain in adults with IBS-D.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06757491

• BN104 combined with chemotherapy or targeted agents for treating acute myeloid leukemia

  This study is testing a new drug called BN104 combined with chemotherapy or targeted treatments to see if it helps people with acute myeloid leukemia feel better and improve their chances of recovery.

  Recruiting Phase 1/2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06746519

• CT0596 CAR-T treatment for relapsed or refractory multiple myeloma and plasma cell leukemia

  This will try a CT0596 CAR‑T cell infusion in adults whose multiple myeloma or plasma cell leukemia has returned or not responded to prior treatments to see if it is safe and can control the disease.

  Recruiting Early Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06730256

• Infusion therapy using CAR-γδT cells for treating relapsed B-Cell leukemia

  This study is testing a new treatment using special immune cells to see if it can help people with relapsed B-Cell leukemia who haven't responded to other therapies.

  Recruiting Early Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, China, Jiangsu · NCT06696833

• Investigating how local anesthetic temperature affects maternal fever during childbirth

  This study tests whether using warmer or cooler local anesthetics during labor can help reduce the chances of mothers getting a fever while receiving epidural pain relief.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT06682416

• Switching to Carfilzomib for Patients Intolerant to Bortezomib in Multiple Myeloma

  This study is testing if switching to a new treatment called carfilzomib helps Chinese patients with multiple myeloma who can't tolerate their previous bortezomib therapy feel better and live longer.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06682156

• Glofitamab treatment for patients with relapsed or refractory DLBCL before stem cell transplant

  This study is testing if Glofitamab can help patients with relapsed or hard-to-treat diffuse large B-cell lymphoma get ready for a stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06682130

• Dapagliflozin to prevent acute graft-versus-host disease after allogeneic stem cell transplant

  This trial will test whether taking dapagliflozin around the time of an allogeneic stem cell transplant can lower the chance of acute graft-versus-host disease in adults with blood cancers.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06626737

• Using TBI and Melphalan for Second Stem Cell Transplantation in Blood Cancer Patients

  This study is testing if using total body radiation and a drug called melphalan can help blood cancer patients who need a second stem cell transplant after their first one didn't work.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06548958

• Comparing different drug combinations for newly diagnosed acute myeloid leukemia

  This study is testing different combinations of drugs to see which one works best for people with newly diagnosed acute myeloid leukemia who can't handle strong chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06532552

• Using blinatumomab with autologous stem cell transplant for B-cell leukemia treatment

  This study is testing a new treatment for adults with B-cell leukemia that combines a drug called blinatumomab with a stem cell transplant to see if it helps improve their chances of recovery.

  Recruiting Phase 1 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06507514

• CMOP±R therapy for newly diagnosed non-Hodgkin's lymphoma

  This study tests CMOP±R in adults with newly diagnosed non-Hodgkin's lymphoma to see if the treatment is safe and effective.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06486337

• MRD-guided treatment for high-risk newly diagnosed multiple myeloma

  This treatment will test whether combining daratumumab, carfilzomib, lenalidomide and dexamethasone, with or without autologous stem‑cell transplant and MRD‑guided maintenance, can keep high‑risk newly diagnosed multiple myeloma patients free of measurable disease for one year.

  Recruiting Phase 4 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06409702

• Combining venetoclax and azacitidine with HAAG for treating newly diagnosed AML

  This study is testing a new combination of medications for people who have just been diagnosed with intermediate and high-risk acute myeloid leukemia to see if it helps them respond better to treatment.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06394011

• Using decitabine, venetoclax, and blinatumomab for maintenance therapy in B-ALL patients after stem cell transplant

  This study is testing a combination of three medications to see if they can help people with B-cell acute lymphoblastic leukemia stay in remission after a stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06393985

• Comparing two types of stem cell transplants for treating T-ALL

  This study is testing if a new type of stem cell transplant that uses both a family donor and cord blood can help people with acute T cell leukemia do better than the standard transplant method.

  Recruiting Phase 3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06381817

• Comparing Blinatumomab with hyperCVAD for treating Philadelphia-negative B-ALL

  This study is testing if combining Blinatumomab with lighter chemotherapy can help young adults with a type of leukemia feel better and have fewer side effects compared to a standard treatment.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06250959

• New treatment for AML patients who didn't respond to initial therapy

  This study is testing a new combination treatment for older patients or younger patients with certain health issues who have Acute Myeloid Leukemia and didn't get better with standard therapy, to see if it can help them go into remission.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06220162

• Using Inotuzumab Ozogamicin to treat MRD-positive ALL after stem cell transplant

  This study is testing if a new treatment called Inotuzumab Ozogamicin can help young adults with a type of leukemia who have had a stem cell transplant and are facing a return of their disease.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05940961

• Comparing two treatments for newly diagnosed high-risk acute myeloid leukemia

  This study is testing whether a new combination of medications can work better than the standard treatment for adults with newly diagnosed high-risk acute myeloid leukemia.

  Recruiting at 2 sites Phase 2/3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT05939180

• Combining Venetoclax and Azacitidine for treating Acute Leukemia of Ambiguous Lineage

  This study is testing if combining two medications, venetoclax and azacitidine, can help people aged 15 to 65 who have just been diagnosed with Acute Leukemia of Ambiguous Lineage feel better and live longer.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou · NCT05901974

• Combining venetoclax with homoharringtonine and cytarabine for treating acute myeloid leukemia

  This study is testing a new combination of three medications to see if it can help younger adults with newly diagnosed acute myeloid leukemia feel better and improve their chances of recovery.

  Recruiting Phase 2/3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05805098

• Combining PD-1 inhibitor with Azacitidine and low-dose DLI for AML relapse after stem cell transplant

  This study is testing a new treatment combining a PD-1 inhibitor, Azacitidine, and low-dose donor lymphocyte infusion to see if it can help people with acute myeloid leukemia who have relapsed after a stem cell transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05772273

• Treatment for relapsed or refractory B-cell acute lymphoblastic leukemia

  This study is testing a new combination treatment for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia to see if it can help them respond better than current options.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05657652

• Treatment for relapsed or refractory acute myeloid leukemia

  This study is testing a new combination treatment for people with relapsed or refractory acute myeloid leukemia to see if it helps them respond better than standard therapies.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05657639

• Creating a database for patients with thrombotic microangiopathies

  This study is creating a detailed database to collect important information about patients with thrombotic microangiopathies to help improve understanding and treatment of the condition.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05634928

• Creating a database for patients with Thrombotic Thrombocytopenic Purpura

  This study is creating a detailed database of information about patients with Thrombotic Thrombocytopenic Purpura to help better understand the condition.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05571774

• Combination treatment for newly diagnosed acute monocytic leukemia

  This study is testing a new combination treatment for people with newly diagnosed acute monocytic leukemia who can't have intensive chemotherapy to see if it helps them feel better and manage their condition.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05566054

• Treatment of FGFR1-rearranged neoplasms with Olverembatinib

  This study is testing if a new drug called Olverembatinib can help people with rare blood cancers caused by FGFR1 changes get better and possibly prepare them for a stem cell transplant.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05521204

• Combining azacitidine and venetoclax for maintenance therapy in younger adults with AML in remission

  This study is testing if combining two medications, azacitidine and venetoclax, can help younger adults with acute myeloid leukemia stay in remission longer after their initial treatment.

  Recruiting at 2 sites Phase 2/3 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu and 1 other locations · NCT05404906

• Combining venetoclax and azacitidine for newly diagnosed T-ALL patients

  This study is testing a new treatment combining venetoclax and azacitidine to see if it helps people aged 15 and older who are newly diagnosed with T-cell acute lymphoblastic leukemia feel better.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05376111

• Anti‑PD‑1 with lenalidomide and azacitidine for relapsed/refractory peripheral T‑cell lymphoma

  This study will test whether adding an anti‑PD‑1 antibody to lenalidomide and azacitidine helps adults with relapsed or refractory peripheral T‑cell lymphoma.

  Recruiting Phase 2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT05182957

• Exploring the link between FODMAPs and Graft Versus Host Disease

  This study is trying to see if certain foods called FODMAPs affect the severity of Graft Versus Host Disease in patients who have had a bone marrow transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT04660487

• Evaluating nutrition in patients after stem cell transplantation

  This study looks at the nutrition of patients who have had stem cell transplants to see how their eating habits and health changes affect their recovery over time.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT04146870

• Comparing Chidamide with VRD for High-Risk Multiple Myeloma

  This study is testing if adding a new drug called chidamide to the standard treatment for high-risk multiple myeloma can help patients do better and feel safer.

  Recruiting Phase 1/2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT04025450

• T Cell Therapy for Chemotherapy Refractory Multiple Myeloma

  This study is testing a new treatment using specially modified immune cells to help adults with hard-to-treat multiple myeloma fight their cancer.

  Recruiting Phase 1/2 The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT03196414

• Using fecal microbiota to treat gut acute graft-versus-host disease

  This study is testing whether fecal microbiota transplantation can help improve gut symptoms in patients with acute graft-versus-host disease after stem cell transplantation.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT03148743

Quick answers

How many clinical trials run by The First Affiliated Hospital of Soochow University are recruiting right now?

90, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 32, Phase 1: 9, Phase 2/3: 5, Phase 1/2: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →